AIM ImmunoTech, Inc. - AIM Company Long-Term Liabilities

Symbol and logo of brand AIM ImmunoTech Inc. (AIM)

The visualized price action of AIM ImmunoTech (AIM) reflects the trajectory of a company that has automated compound bioscreening to reduce the workload of scientists. The current metric stands at 0.00. The business is navigating regulatory challenges and leveraging patents to protect its position in the fight for market share. Future prospects rely on the drug Ampligen, as FDA recognition for the treatment of cancer and long COVID could secure global success.

AIM aimimmuno.com Company Long-Term Liabilities (07/04/2022 - 10/28/2026)

AIM ImmunoTech Inc. - analytical breakdowns and key metrics (AIM)

- price and consensus price forecast:
Price Performance Chart aimimmuno.com|AIM - Price Target Chart
- market capitalization data:
Market Valuation AIM ImmunoTech|AIM - Enterprise Value
- book capitalization data:
Book Value per Share AIM ImmunoTech|AIM - Company Net Assets|Market Value to Book Value aimimmuno.com|AIM - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient AIM ImmunoTech|AIM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio AIM ImmunoTech, Inc.|AIM - Company Debts|Debt to Book Value AIM ImmunoTech|AIM - Company Long-Term Liabilities|Company Short-Term Debts AIM ImmunoTech
Fundamental company valuation:AIM - aimimmuno.com
Manufactured products of AIM ImmunoTech

Amidst a fierce battle for medical budgets against Big Pharma, AIM ImmunoTech requires stable capital. This indicator aggregates all obligations with maturities exceeding one year, determining the long-term debt load. The metric allows for an assessment of the degree of financial leverage and the resilience of the capital structure to market shocks. It is critical for investors to correlate borrowing rates with drug development progress. The corporation's history of long-term loans and borrowings clearly demonstrates the balance between debt financing and financial autonomy.

Who AIM ImmunoTech competes with

argenx.com - Company Long-Term Loans and Borrowings|BNTX: Company Long-Term Debt|ABVX - Company Long-Term Liabilities|ADMA: Company Long-Term Debts|Company Long-Term Debts Protagonist Corp|IMVT - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings kiniksa.com|GRFS (Grifols) - Company Long-Term Debts|Long-Term Debt Volume ADPT (Adaptive Biotech)|Celldex - Company Long-Term Debt|Aurinia Corp - Company Long-Term Liabilities|BCRX: Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|DNTH: Company Long-Term Liabilities|PHVS (Pharvaris NV) - Company Long-Term Debts|Company Long-Term Debt AbCellera Biologics (ABCL)|Company Long-Term Indebtedness Tourmaline|Precigen, Inc. - Company Long-Term Debts|Long-Term Debt pharming.com (PHAR)|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Company Long-Term Debts Upstream Bio, Inc. UPB|Company Long-Term Debts ZBIO (Zenas Biopharma, Inc.)|IMNM: Long-Term Debt Volume|GOSS (Gossamer Bio, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities kalvista.com|SEPN - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Pieris Pharma|SVRA (Savara Corp) - Company Long-Term Debts|Long-Term Debt Volume RIGL (Rigel Corp)|AnaptysBio, Inc. - Company Long-Term Debt|astriatx.com - Company Long-Term Liabilities|ENGN: Company Long-Term Debt|rapt.com (RAPT) - Company Long-Term Liabilities|JBIO: Company Long-Term Liabilities|ACRS (Aclaris Therapeutics, Inc) - Company Long-Term Debts|Company Long-Term Debt Kyverna Therapeutics (KYTX)|Company Long-Term Indebtedness TLSA|Cabaletta Bio - Company Long-Term Debt|Long-Term Debt Ventyx Biosciences Inc. VTYX|Company Long-Term Liabilities Theratechnologies Inc (THTX)|Amount of Long-Term Liabilities Avalo Therapeutics Inc AVTX|ELDN (Eledon Pharmaceuticals) - Company Long-Term Debts|AGEN - Long-Term Debt|CLYM (Climb Bio) - Company Long-Term Debts|zurabio.com (ZURA) - Company Long-Term Liabilities|ATYR - Company Long-Term Debts|Company Long-Term Loans and Borrowings Adagene Corp|Company Long-Term Debts IMA|Company Long-Term Debts shattucklabs.com (STTK)|Company Long-Term Debts EQ|Connect Biopharma Holdings - Long-Term Debt Volume|IMUX: Company Long-Term Debt|ATRA: Company Long-Term Liabilities|Company Long-Term Debt inflarx.de (IFRX)|x4pharma.com (XFOR) - Long-Term Liabilities|ACET - Company Long-Term Debts|Company Long-Term Loans and Borrowings Celularity Corp|Company Long-Term Debts INMB|Company Long-Term Debts BRNS (Barinthus Biotherapeutics Corp)|Company Long-Term Debt Kezar Life Sciences|sabbiotherapeutics.com - Company Long-Term Loans and Borrowings|AKTX: Company Long-Term Debt|ENLV - Company Long-Term Liabilities|QTTB: Company Long-Term Debts|Company Long-Term Debts GeoVax Corp|EDSA - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ibioinc.com|CARM (Carisma Therapeutics) - Company Long-Term Debts|Long-Term Debt Volume XTLB (XTL Biopharmaceuticals Ltd)|Bolt Biotherapeutics, Inc. - Company Long-Term Debt|HCW Biologics, Inc. - Company Long-Term Liabilities|APVO: Company Long-Term Debt|Aditxt (ADTX) - Company Long-Term Liabilities|GRI: Company Long-Term Liabilities|XRTX (XORTX Therapeutics Inc) - Company Long-Term Debts|Company Long-Term Debt ReShape Lifesciences (HIND)|Company Long-Term Indebtedness Revelation Biosciences Corp|Indaptus Therapeutics - Company Long-Term Debts|Long-Term Debt scinai.com (SCNI)|Company Long-Term Debts CALI (CalciMedica)|Company Long-Term Debts Affimed NV AFMD|Company Long-Term Debts ALLK (Allakos Therapeutics)|HOOK: Long-Term Debt Volume|IGMS (igmbio.com) - Company Long-Term Debt|Company Long-Term Liabilities iteostherapeutics.com|OCEA - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings TC BioPharm (Holdings) Plc|THRD (Third Harmonic Bio, Inc) - Company Long-Term Debts